These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18822956)

  • 1. [Recent progress in the study on antitumor drugs targeting hypoxia-inducible factor-1].
    Wang JJ; Li J; Geng MY
    Yao Xue Xue Bao; 2008 Jun; 43(6):565-9. PubMed ID: 18822956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual effect of echinomycin on hypoxia-inducible factor-1 activity under normoxic and hypoxic conditions.
    Vlaminck B; Toffoli S; Ghislain B; Demazy C; Raes M; Michiels C
    FEBS J; 2007 Nov; 274(21):5533-42. PubMed ID: 17916190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part II.
    Wilczynski J; Duechler M; Czyz M
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):301-7. PubMed ID: 21625847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
    Shi M; Guo XT; Shu MG; Chen FL; Li LW
    Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypoxic inducible stress response as a target for cancer drug discovery.
    Welsh SJ; Koh MY; Powis G
    Semin Oncol; 2006 Aug; 33(4):486-97. PubMed ID: 16890803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor 1 inhibitors.
    Melillo G
    Methods Enzymol; 2007; 435():385-402. PubMed ID: 17998065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
    Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
    Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strongylophorines: natural product inhibitors of hypoxia-inducible factor-1 transcriptional pathway.
    Mohammed KA; Jadulco RC; Bugni TS; Harper MK; Sturdy M; Ireland CM
    J Med Chem; 2008 Mar; 51(5):1402-5. PubMed ID: 18278856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction.
    Tanaka T; Wiesener M; Bernhardt W; Eckardt KU; Warnecke C
    Biochem J; 2009 Oct; 424(1):143-51. PubMed ID: 19694616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of HIF-1 inhibitors as anticancer agents.
    Semenza GL
    Drug Discov Today; 2007 Oct; 12(19-20):853-9. PubMed ID: 17933687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF gene expression in cancer therapy.
    Chan DA; Krieg AJ; Turcotte S; Giaccia AJ
    Methods Enzymol; 2007; 435():323-45. PubMed ID: 17998061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs target hypoxia response in tumors.
    Garber K
    J Natl Cancer Inst; 2005 Aug; 97(15):1112-4. PubMed ID: 16077066
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of hypoxia-inducible factors during inflammation.
    Frede S; Berchner-Pfannschmidt U; Fandrey J
    Methods Enzymol; 2007; 435():405-19. PubMed ID: 17998066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1.
    Toffoli S; Roegiers A; Feron O; Van Steenbrugge M; Ninane N; Raes M; Michiels C
    Angiogenesis; 2009; 12(1):47-67. PubMed ID: 19184477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor hypoxia in cancer therapy.
    Brown JM
    Methods Enzymol; 2007; 435():297-321. PubMed ID: 17998060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
    Miyazawa M; Yasuda M; Fujita M; Kajiwara H; Hirabayashi K; Takekoshi S; Hirasawa T; Murakami M; Ogane N; Kiguchi K; Ishiwata I; Mikami M; Osamura RY
    Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
    Poon E; Harris AL; Ashcroft M
    Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can tumor hypoxia be turned into a chemotherapeutic advantage?].
    Trédan O; Grantab R; Dumontet C
    Bull Cancer; 2008 May; 95(5):528-34. PubMed ID: 18541517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain.
    Trollmann R; Gassmann M
    Brain Dev; 2009 Aug; 31(7):503-9. PubMed ID: 19398180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.